Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sudden Cardiac Death.

Goldberger1

  • 1Northwestern Memorial Hospital, 250 East Superior Street, Wesley Pavilion, Suite #520, Chicago, IL 60611, USA.

Current Treatment Options in Cardiovascular Medicine
|November 30, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ionic exchanges of turtle shell in vitro and their relevance to shell function in the anoxic turtle

The Journal of experimental biology·1999
Same author

Laparoscopic Resection of a Cornual Pregnancy: A First Case Report

The Journal of the American Association of Gynecologic Laparoscopists·1994
Same journal

An Update on the Role of Renal Artery Denervation in the Treatment of Hypertension.

Current treatment options in cardiovascular medicine·2026
Same journal

Advancements and Challenges in Contemporizing Care for Adult Patients with Congenital Heart Disease and Advanced Heart Failure: An Update on Application of Modern Heart Failure Technologies.

Current treatment options in cardiovascular medicine·2026
Same journal

Evolving Decongestion Strategies in the Management of Acute Heart Failure.

Current treatment options in cardiovascular medicine·2025
Same journal

Advanced Electroanatomic Mapping: Current and Emerging Approaches.

Current treatment options in cardiovascular medicine·2025
Same journal

Metabolic Reprogramming in Heart Failure: From Energy Starvation to Therapeutic Targets.

Current treatment options in cardiovascular medicine·2025
Same journal

Drug-Coated Balloons for Coronary Artery Disease: From Theory to Practice.

Current treatment options in cardiovascular medicine·2025
See all related articles

Sudden cardiac death prevention strategies focus on high-risk patients. Implantable cardioverter-defibrillators (ICDs) are the current best approach for preventing sudden cardiac death in these individuals.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Preventive Medicine

Background:

  • Sudden cardiac death (SCD) management has advanced, yet recurrence risk remains high for survivors.
  • Large populations without prior SCD are also at significant risk, necessitating prophylactic measures.
  • Low survival rates from out-of-hospital cardiac arrest underscore the need for targeted prevention.

Purpose of the Study:

  • To review current strategies for preventing sudden cardiac death.
  • To identify high-risk populations benefiting from prophylactic interventions.
  • To evaluate the role of pharmacologic therapy and implantable cardioverter-defibrillators (ICDs) in SCD prevention.

Main Methods:

  • Review of existing literature on sudden cardiac death management and prophylaxis.

Related Experiment Videos

  • Analysis of the efficacy of beta-blockers, antiarrhythmic drugs, and ICDs.
  • Discussion of patient selection criteria for prophylactic therapies.

    • Main Results:

    • Beta-blockers are effective for patients with myocardial infarction and heart failure.
    • Most antiarrhythmic drugs (Class I, III) lack proven efficacy in reducing mortality for SCD prevention, with amiodarone as a potential exception.
    • Implantable cardioverter-defibrillators (ICDs) are the current therapy of choice for hemodynamically significant ventricular tachyarrhythmias or aborted SCD.

    Conclusions:

    • Identifying high-risk populations is critical for effective sudden cardiac death management.
    • Implantable cardioverter-defibrillators (ICDs) represent the most effective prophylactic approach for selected high-risk individuals.
    • Further research is needed to refine risk stratification and optimize preventive strategies for sudden cardiac death.